Tierra Biosciences - About the company
Tierra Biosciences is a series A company based in Berkeley (United States), founded in 2015 by Zachary Sun. It operates as a Provider of AI-based tools for development and custom synthesis of protiens. Tierra Biosciences has raised $31.6M in funding from Social Capital and Material Impact. The company has 13 active competitors, including 5 funded and 1 that has exited. Its top competitors include companies like Nuclera, Encodia and Amide Technologies.
Company Details
Provider of AI-based tools for development and custom synthesis of protiens. It offers bio-discovery using cell-free systems, computer learning, and metagenomics to study the molecule diversity of different DNA sequences. It offers the cell-free system for synthetic biology for the diversity of life, including gram-positive, gram-negative, and eukaryotic species.
- Website
- tierrabiosciences.com
- Email ID
- *****@tierrabiosciences.com
- Phone Number
- +1 **********
- Registered Address
- San Francisco, California
Key Metrics
Founded Year
2015
Location
Berkeley, United States
Stage
Series A
Total Funding
$31.6M in 10 rounds
Latest Funding Round
Investors
Ranked
3rd among 13 active competitors
Employee Count
11 as on Sep 30, 2026
Legal entities associated with Tierra Biosciences
Tierra Biosciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
SYNVITROBIO INC. CIN: 473353999 , United States, Active | Dec 26, 999 | - | 11 (As on Dec 31, 2022) | - |
Sign up to download Tierra Biosciences' company profile
Tierra Biosciences's funding and investors
Tierra Biosciences has raised a total funding of $31.6M over 10 rounds. Its first funding round was on Jan 01, 2016. Its latest funding round was a Series A round on Mar 12, 2024 for $*****. 7 investors participated in its latest round. Tierra Biosciences has 15 institutional investors.
Here is the list of recent funding rounds of Tierra Biosciences:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 12, 2024 | 2348470 | Series A | 8029198 | 3618659 | 1994031 | 9649664 |
Sep 22, 2023 | 2274394 | Series A | 2548480 | 4980033 | 9189014 | 7749005 |
Sep 11, 2020 | 7916832 | Grant (prize money) | 1121125 | 1610767 | 6129471 |
View details of Tierra Biosciences's funding rounds and investors
Tierra Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Tierra Biosciences is Zachary Sun.
Here are the details of Tierra Biosciences' key team members:
- Zachary Sun: Co-Founder of Tierra Biosciences. Contact Info: 1 email address
View details of Tierra Biosciences's Founder profiles and Board Members
Tierra Biosciences' employee count trend
Tierra Biosciences has 11 employees as of Sep 26. Here is Tierra Biosciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Tierra Biosciences's Competitors and alternates
Top competitors of Tierra Biosciences include Nuclera, Encodia and Amide Technologies. Here is the list of Top 10 competitors of Tierra Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Nuclera 2013, Cambridge (United Kingdom), Series C | Provider of rapid protein expression and screening systems for biotechnology labs | $176M | 68/100 | |
2nd | Encodia 2015, San Diego (United States), Series C | Developer of technology platforms for integrative proteomic analysis | $75M | 50/100 | |
3rd | Tierra Biosciences 2015, Berkeley (United States), Series A | Provider of AI-based tools for development and custom synthesis of protiens | $31.6M | 45/100 | |
4th | Amide Technologies 2017, Cambridge (United States), Series A | Developer of automated peptide synthesis platform | $16.5M | 39/100 | |
5th | California Peptide Research 1993, Salt Lake City (United States), Acquired | Online casino offering diverse games, bonuses, and secure gaming experience | - | - | 28/100 |
6th | mk2 Biotechnologies 2017, Munich (Germany), Seed | Developer of peptides and proteins for life science applications | - | 27/100 | |
7th | Designer BioScience 2008, Cambridge (United Kingdom), Unfunded | Custom peptide synthesis | - | - | 24/100 |
8th | Advanced Peptides 2007, Boston (United States), Unfunded | Premier CRO providing custom peptides, peptide libraries, and biologics for research | - | - | 24/100 |
9th | Celine Therapeutics 2022, United States, Funding Raised | Provider of AI interfaced protein synthesis therapies through automation and computation | - | 22/100 | |
10th | Aquagene 1996, Alachua (United States), Deadpooled | Manufacturer of recombinant proteins. | $980K | 19/100 |
Looking for more details on Tierra Biosciences's competitors? Click here to see the top ones
Tierra Biosciences's Investments and acquisitions
Tierra Biosciences has made no investments or acquisitions yet.
Reports related to Tierra Biosciences
Here is the latest report on Tierra Biosciences's sector:
News related to Tierra Biosciences
•
Tierra raises $11.4 in Series A round for predictive AI protein makerPharmaceutical Technology•Mar 12, 2024•Tierra Agrotech, Material Impact, Tierra Biosciences, Prosus and 8 others
•
Terremoto Biosciences Launches With $75 Million Series A Financing and Mission to Discover and Develop Groundbreaking Covalent MedicinesBusiness Wire•May 25, 2022•Tierra Biosciences, Orbimed, Third Rock Ventures, Terremoto
•
Tierra Biosciences Appoints Michael Nemzek as Chief Executive OfficerBusiness Wire•May 03, 2022•Tierra Biosciences, Material Impact
•
Tierra Biosciences Launches First-Ever Online Protein Ordering Platform for Synthetic Biology Protein EngineeringBusiness Wire•Feb 02, 2022•Tierra Biosciences
•
Synvitrobio Rebrands as Tierra Biosciences, Announces $2.6M Seed Round to Discover Unexplored Areas of BiologyBusiness Wire•Sep 11, 2018•Tierra Biosciences, Social Capital, Fifty Years, KdT Ventures
•
As biological manufacturing moves to the mainstream, Synvitrobio rebrands and raises cashtechnewsuniverse.com•Sep 11, 2018•Synvitrobio, Tierra Biosciences, Social Capital, Fifty Years and 1 other
Are you a Founder ?
FAQs about Tierra Biosciences
Explore our recently published companies
- Halmblog Music - Accra based, 2022 founded, Unfunded company
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
- eomii - Unfunded company
- HOLTWORK - Unfunded company
